Ginsenoside Rg1 Ameliorates Cardiac Oxidative Stress and Inflammation in Streptozotocin-induced Diabetic Rats

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2019 Aug 3

PMID 31372019

Citations 23

Authors

Qiaoji Qin

Nan Lin

Huan Huang

Xuezhi Zhang

Xuelei Cao

Yongbin Wang

Peng Li

Affiliations

Soon will be listed here.

Abstract

Ginsenoside Rg1 (GS Rg1), as an important active substance of Panax ginseng, has been proven to have elaborate cardioprotective effects. The purpose of this study was to detect that GS Rg1 attenuates cardiac oxidative stress and inflammation in streptozotocin (STZ)-induced diabetic rats (DM). Cardiac function was assessed by heart rate and blood pressure. Markers relevant to myocardial oxidative stress and antioxidant capacity, and inflammatory reaction factors were detected. The mRNA and protein expression were detected by RT-qPCR and Western blot, respectively. GS Rg1 treatment signiﬁcantly reduced the symptoms of cardiac hypertrophy and hypertension, and also decreased oxidative stress, inflammation response, NF-κB expression and NLRP3 inflammasome expression. GS Rg1 enhanced mitochondrial biogenesis by increasing PGC-1α, complex III and complex Ⅳ expression. GS Rg1 treatment significantly increased the expression of AMPK, Nrf2 and HO-1 in cardiac tissues. GS Rg1 exhibited protective effect against STZ-induced cardiac dysfunction, which is potentially associated with AMPK/Nrf2/HO-1 signal pathway.

Citing Articles

Ginsenoside Rg1 regulating inflammatory response and bone-remodeling through Keap1/Nrf2 signaling pathway in rats with periodontitis.

Zhou Y, Zhang Y, Wang L, Liu Y, Wang Z, Guo L Sci Rep. 2025; 15(1):7478.

PMID: 40033022 PMC: 11876643. DOI: 10.1038/s41598-025-92165-8.

Inhibition of Myocardial Remodeling and Heart Failure by Traditional Herbal Medications: Evidence from Ginseng and .

Karmazyn M, Gan X Rev Cardiovasc Med. 2024; 24(7):212.

PMID: 39077021 PMC: 11266468. DOI: 10.31083/j.rcm2407212.

Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites.

Pan X, Hao E, Zhang F, Wei W, Du Z, Yan G Front Pharmacol. 2024; 15:1401961.

PMID: 39045049 PMC: 11263127. DOI: 10.3389/fphar.2024.1401961.

Mass Production of Rg1-Loaded Small Extracellular Vesicles Using a 3D Bioreactor System for Enhanced Cardioprotective Efficacy of Doxorubicin-Induced Cardiotoxicity.

Di Y, Zhao S, Fan H, Li W, Jiang G, Wang Y Pharmaceutics. 2024; 16(5).

PMID: 38794255 PMC: 11126075. DOI: 10.3390/pharmaceutics16050593.

Ginsenoside Rg1 Alleviates Sepsis-Induced Acute Lung Injury by Reducing FBXO3 Stability in an mA-Dependent Manner to Activate PGC-1α/Nrf2 Signaling Pathway.

Liu R, Wang Q, Li Y, Wan R, Yang P, Yang D AAPS J. 2024; 26(3):47.

PMID: 38622374 DOI: 10.1208/s12248-024-00919-5.

References

Singal P, Bello-Klein A, Farahmand F, Sandhawalia V . Oxidative stress and functional deficit in diabetic cardiomyopathy. Adv Exp Med Biol. 2002; 498:213-20. DOI: 10.1007/978-1-4615-1321-6_27. View

Zong H, Ren J, Young L, Pypaert M, Mu J, Birnbaum M . AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A. 2002; 99(25):15983-7. PMC: 138551. DOI: 10.1073/pnas.252625599. View

Russell L, Mansfield C, Lehman J, Kovacs A, Courtois M, Saffitz J . Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res. 2004; 94(4):525-33. DOI: 10.1161/01.RES.0000117088.36577.EB. View

Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O . Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005; 1(4):259-71. DOI: 10.1016/j.cmet.2005.03.002. View

Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M . Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2005; 55(1):120-7. View

Boudina S, Abel E . Diabetic cardiomyopathy revisited. Circulation. 2007; 115(25):3213-23. DOI: 10.1161/CIRCULATIONAHA.106.679597. View

Boudina S, Sena S, Theobald H, Sheng X, Wright J, Hu X . Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007; 56(10):2457-66. DOI: 10.2337/db07-0481. View

Piantadosi C, Carraway M, Babiker A, Suliman H . Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res. 2008; 103(11):1232-40. PMC: 2694963. DOI: 10.1161/01.RES.0000338597.71702.ad. View

Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C . Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J Biol Chem. 2008; 284(5):3058-3068. DOI: 10.1074/jbc.M805329200. View

10.

Lu J, Yao Q, Chen C . Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009; 7(3):293-302. PMC: 2928028. DOI: 10.2174/157016109788340767. View

11.

Mariappan N, Elks C, Sriramula S, Guggilam A, Liu Z, Borkhsenious O . NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2009; 85(3):473-83. PMC: 2860708. DOI: 10.1093/cvr/cvp305. View

12.

Wang X, Gu T, Shi E, Lu C, Wang C . Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats. Chin J Integr Med. 2010; 16(2):162-6. DOI: 10.1007/s11655-010-0162-4. View

13.

van Dieren S, Beulens J, van der Schouw Y, Grobbee D, Neal B . The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010; 17 Suppl 1:S3-8. DOI: 10.1097/01.hjr.0000368191.86614.5a. View

14.

Vandanmagsar B, Youm Y, Ravussin A, Galgani J, Stadler K, Mynatt R . The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011; 17(2):179-88. PMC: 3076025. DOI: 10.1038/nm.2279. View

15.

Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H . Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation. 2011; 123(6):594-604. DOI: 10.1161/CIRCULATIONAHA.110.982777. View

16.

Miki T, Yuda S, Kouzu H, Miura T . Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2012; 18(2):149-66. PMC: 3593009. DOI: 10.1007/s10741-012-9313-3. View

17.

Maier H, Schips T, Wietelmann A, Kruger M, Brunner C, Sauter M . Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure. Proc Natl Acad Sci U S A. 2012; 109(29):11794-9. PMC: 3406816. DOI: 10.1073/pnas.1116584109. View

18.

Asrih M, Steffens S . Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc Pathol. 2012; 22(2):117-25. DOI: 10.1016/j.carpath.2012.07.004. View

19.

Qazi M, Malik S . Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study. Glob Heart. 2013; 8(1):43-48. PMC: 3610922. DOI: 10.1016/j.gheart.2012.12.008. View

20.

Zhang Y, Zhang X, Li M, Iqbal J, Bourantas C, Li J . The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol. 2013; 62(1):50-7. DOI: 10.1097/FJC.0b013e31828f8d45. View